Related Experiment Video
Updated: Jun 8, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Non-infectious serious hazards in plasma transfusion
1Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Langhansstr. 7, 35392 Giessen, Germany.
Plasma transfusions carry risks. This overview covers non-infectious side effects, separating blood safety issues from clinical transfusion safety concerns, which remains a key challenge.
Area of Science:
- Transfusion Medicine
- Hematology
- Patient Safety
Background:
- Plasma transfusion is a critical component of hemotherapy.
- However, its use is associated with potential non-infectious hazards.
- These hazards can be broadly categorized into blood safety and transfusion safety.
Purpose of the Study:
- To provide an overview of non-infectious side-effects of plasma transfusion.
- To differentiate between hazards related to blood collection/processing and clinical application.
- To highlight the current and future challenges in plasma therapy safety.
Main Methods:
- Literature review and synthesis of existing data on plasma transfusion side effects.
- Categorization of non-infectious hazards into blood safety (donor/processing) and transfusion safety (clinical use).
- Analysis of the impact of preventive measures on transfusion-related acute lung injury (TRALI).
Main Results:
- Significant progress has been made in ensuring blood safety for plasma, with preventive measures for TRALI widely implemented.
- Blood safety aspects related to plasma donation and processing are approaching a high level of security.
- Transfusion safety, concerning the clinical administration of plasma, continues to present relevant challenges.
Conclusions:
- While blood safety in plasma therapy has improved considerably, transfusion safety remains a critical area requiring ongoing attention.
- Future efforts in plasma therapy must focus on mitigating risks associated with the clinical use of plasma.
- Addressing transfusion safety issues is essential for the continued advancement and safe application of plasma therapy.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Hemodialysis II: Procedure and Complications
Hemorrhagic Stroke ll: Pathophysiology
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
